Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate-Reference-Cited by-同舟云学术

Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate

Published:2021-09-13 Issue:1 Volume:63 Page:239-242
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Costa Philippos Apolinario¹^ORCID,Espejo-Freire Andrea Patricia²,Fan Kenneth Chen³,Albini Thomas Arno³,Pongas Georgios²

Affiliation:

1. Department of Medicine, Division of Internal Medicine, University of Miami Miller School of Medicine, Miami, FL, USA

2. Department of Medicine, Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA

3. Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1978090

Reference15 articles.

1. Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

2. Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma

3. Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

4. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review;Frontiers in Oncology;2024-08-05

2. Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies;The Oncologist;2024-07-24

3. Cardiac toxicity of brentuximab vedotin: a real-word disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-25

4. Ocular side effects of oncological therapies: Review;Archivos de la Sociedad Española de Oftalmología (English Edition);2023-11

5. Efectos secundarios oculares de las terapias oncológicas. Revisión;Archivos de la Sociedad Española de Oftalmología;2023-10